APA (7th ed.) Citation

T, B., F, L., S, R., C, S., D, C., D, H., . . . EM, R. (2026). Baseline and placebo-related imaging, cerebrospinal fluid, plasma biomarker, and cognitive findings in unimpaired PSEN1 E280A mutation carriers and non-carriers in the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia Trial. EBioMedicine, 130, 106390. https://doi.org/10.1016/j.ebiom.2026.106390

Chicago Style (17th ed.) Citation

T, Bittner, et al. "Baseline and Placebo-related Imaging, Cerebrospinal Fluid, Plasma Biomarker, and Cognitive Findings in Unimpaired PSEN1 E280A Mutation Carriers and Non-carriers in the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia Trial." EBioMedicine 130 (2026): 106390. https://doi.org/10.1016/j.ebiom.2026.106390.

MLA (9th ed.) Citation

T, Bittner, et al. "Baseline and Placebo-related Imaging, Cerebrospinal Fluid, Plasma Biomarker, and Cognitive Findings in Unimpaired PSEN1 E280A Mutation Carriers and Non-carriers in the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia Trial." EBioMedicine, vol. 130, 2026, p. 106390, https://doi.org/10.1016/j.ebiom.2026.106390.